| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802
|
Holtan, Shernan G.
|
|
|
2 |
15 |
p. 1882-1888
|
artikel
|
| 2 |
A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia
|
Aslostovar, Lili
|
|
|
2 |
15 |
p. 1935-1945
|
artikel
|
| 3 |
Application of a radiosensitivity flow assay in a patient with DNA ligase 4 deficiency
|
Buchbinder, David
|
|
|
2 |
15 |
p. 1828-1832
|
artikel
|
| 4 |
CD40L/IL-4–stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM
|
Lezina, Larissa
|
|
|
2 |
15 |
p. 1869-1881
|
artikel
|
| 5 |
Characterization of Tfrc-mutant mice with microcytic phenotypes
|
Conway, Ashlee J.
|
|
|
2 |
15 |
p. 1914-1922
|
artikel
|
| 6 |
Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p
|
Barnes, James I.
|
|
|
2 |
15 |
p. 1946-1956
|
artikel
|
| 7 |
CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas
|
Le, Kieu-Suong
|
|
|
2 |
15 |
p. 1889-1900
|
artikel
|
| 8 |
Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels
|
Tefferi, Ayalew
|
|
|
2 |
15 |
p. 1980-1984
|
artikel
|
| 9 |
Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis
|
Nayak, Manasa K.
|
|
|
2 |
15 |
p. 2029-2038
|
artikel
|
| 10 |
Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)
|
Daak, Ahmed A.
|
|
|
2 |
15 |
p. 1969-1979
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
2 |
15 |
p. i
|
artikel
|
| 12 |
Elevated ecto-5′-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease
|
Liu, Hong
|
|
|
2 |
15 |
p. 1957-1968
|
artikel
|
| 13 |
Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma
|
Mundy-Bosse, Bethany
|
|
|
2 |
15 |
p. 1818-1827
|
artikel
|
| 14 |
How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD
|
Jaglowski, Samantha M.
|
|
|
2 |
15 |
p. 2012-2019
|
artikel
|
| 15 |
Induced pluripotent stem cell–based mapping of β-globin expression throughout human erythropoietic development
|
Vanuytsel, Kim
|
|
|
2 |
15 |
p. 1998-2011
|
artikel
|
| 16 |
Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production
|
Htwe, Soe Soe
|
|
|
2 |
15 |
p. 1923-1934
|
artikel
|
| 17 |
Mechanisms of establishment and functional significance of DNA demethylation during erythroid differentiation
|
Bartholdy, Boris
|
|
|
2 |
15 |
p. 1833-1852
|
artikel
|
| 18 |
Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1(24):2295-2301.
|
|
|
|
2 |
15 |
p. 1817
|
artikel
|
| 19 |
Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab
|
Hasanov, Merve
|
|
|
2 |
15 |
p. 1865-1868
|
artikel
|
| 20 |
Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation
|
Inamoto, Yoshihiro
|
|
|
2 |
15 |
p. 1901-1913
|
artikel
|
| 21 |
Richardson PG, Carreras E, Iacobelli M, Nejadnik B. The use of defibrotide in blood and marrow transplantation. Blood Adv. 2018;2(12):1495-1509.
|
|
|
|
2 |
15 |
p. 1853
|
artikel
|
| 22 |
Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment
|
Georges, George E.
|
|
|
2 |
15 |
p. 2020-2028
|
artikel
|
| 23 |
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia
|
Jalali, Shahrzad
|
|
|
2 |
15 |
p. 1985-1997
|
artikel
|
| 24 |
The molecular genetic background leading to the formation of the human erythroid-specific Xga/CD99 blood groups
|
Yeh, Chih-Chun
|
|
|
2 |
15 |
p. 1854-1864
|
artikel
|
| 25 |
Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories
|
Loghavi, Sanam
|
|
|
2 |
15 |
p. 1807-1816
|
artikel
|
Tijdschrift beschrijving